For: | Liu WB, Wang XP, Wu K, Zhang RL. Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells. World J Gastroenterol 2005; 11(41): 6489-6494 [PMID: 16425421 DOI: 10.3748/wjg.v11.i41.6489] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i41/6489.htm |
Number | Citing Articles |
1 |
Ruixia Liu, Haiyu Qi, Jing Wang, Yan Wang, Lijian Cui, Yan Wen, Chenghong Yin. Angiotensin‐converting enzyme (ACE and ACE2) imbalance correlates with the severity of cerulein‐induced acute pancreatitis in mice. Experimental Physiology 2014; 99(4): 651 doi: 10.1113/expphysiol.2013.074815
|
2 |
J. R. A. Skipworth, G. Szabadkai, S. W. M. Olde Damink, P. S. Leung, S. E. Humphries, H. E. Montgomery. Review article: pancreatic renin-angiotensin systems in health and disease. Alimentary Pharmacology & Therapeutics 2011; 34(8): 840 doi: 10.1111/j.1365-2036.2011.04810.x
|
3 |
Cody C. Rounds, Dalliya Rabei, Jasmine T. Williams, Sanzida Haque, Dhruv Ranjan, Chengyue Li, Richard Cisek, Rama S. Madhurapantula, Danielle Tokarz, Thomas C. Irving, Marcella Vaicik, Kenneth M. Tichauer, Conor L. Evans, Kin Foong Chan. Addition of an ECM remodeling drug improves target engagement of immunotherapy in solid pancreatic cancer tumors. Visualizing and Quantifying Drug Distribution in Tissue VIII 2024; : 3 doi: 10.1117/12.3002624
|
4 |
Delanyo Kpeglo, Malcolm Haddrick, Margaret A. Knowles, Stephen D. Evans, Sally A. Peyman. Modelling and breaking down the biophysical barriers to drug delivery in pancreatic cancer. Lab on a Chip 2024; 24(4): 854 doi: 10.1039/D3LC00660C
|
5 |
Bradley R. Hall, Andrew Cannon, Christopher Thompson, Bindu Santhamma, Alejandra Chavez-Riveros, Rakesh Bhatia, Hareesh B. Nair, Klaus Nickisch, Surinder K. Batra, Sushil Kumar. Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma. Genes & Cancer 2018; 10(1-2): 1 doi: 10.18632/genesandcancer.184
|
6 |
Vikash P. Chauhan, John D. Martin, Hao Liu, Delphine A. Lacorre, Saloni R. Jain, Sergey V. Kozin, Triantafyllos Stylianopoulos, Ahmed S. Mousa, Xiaoxing Han, Pichet Adstamongkonkul, Zoran Popović, Peigen Huang, Moungi G. Bawendi, Yves Boucher, Rakesh K. Jain. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nature Communications 2013; 4(1) doi: 10.1038/ncomms3516
|
7 |
Timucin Avsar, Berfu Nur Yigit, Gizem Turan, Deniz Altunsu, Seyma Calis, Bahar Kurt, Turker Kilic, M. Yavuz Ergun, Serdar Durdagi, Melih Acar. Development of imidazolone based angiotensin II receptor type I inhibitor small molecule as a chemotherapeutic agent for cell cycle inhibition. All Life 2021; 14(1): 678 doi: 10.1080/26895293.2021.1954098
|
8 |
Po Sing Leung, Yuk Cheung Chan. Role of Oxidative Stress in Pancreatic Inflammation. Antioxidants & Redox Signaling 2009; 11(1): 135 doi: 10.1089/ars.2008.2109
|
9 |
Po Sing Leung. The Renin-Angiotensin System: Current Research Progress in The Pancreas. Advances in Experimental Medicine and Biology 2010; 690: 89 doi: 10.1007/978-90-481-9060-7_6
|
10 |
Amanda Murphy, Terry LeVatte, Colton Boudreau, Craig Midgen, Paul Gratzer, Jean Marshall, Michael Bezuhly. Angiotensin II Type I Receptor Blockade Is Associated with Decreased Cutaneous Scar Formation in a Rat Model. Plastic & Reconstructive Surgery 2019; 144(5): 803e doi: 10.1097/PRS.0000000000006173
|
11 |
A. Allam, A.R. Thomsen, M. Gothwal, D. Saha, J. Maurer, T.B. Brunner. Pancreatic stellate cells in pancreatic cancer: In focus. Pancreatology 2017; 17(4): 514 doi: 10.1016/j.pan.2017.05.390
|
12 |
Laura De Lellis, Serena Veschi, Nicola Tinari, Zhirajr Mokini, Simone Carradori, Davide Brocco, Rosalba Florio, Antonino Grassadonia, Alessandro Cama. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. Cancers 2021; 13(16): 3946 doi: 10.3390/cancers13163946
|
13 |
Yuk Cheung Chan, Po Sing Leung. The Renin–Angiotensin System and Reactive Oxygen Species: Implications in Pancreatitis. Antioxidants & Redox Signaling 2011; 15(10): 2743 doi: 10.1089/ars.2011.4071
|
14 |
Qingfu Zhao, Jitang Chen, Zhijie Zhang, Chen Xiao, Haowen Zeng, Chen Xu, Xiangliang Yang, Zifu Li. Modulating tumor mechanics with nanomedicine for cancer therapy. Biomaterials Science 2023; 11(13): 4471 doi: 10.1039/D3BM00363A
|
15 |
Qiaoke Gong, Molly Davis, Galina Chipitsyna, Charles J. Yeo, Hwyda A. Arafat. Blocking Angiotensin II Type 1 Receptor Triggers Apoptotic Cell Death in Human Pancreatic Cancer Cells. Pancreas 2010; 39(5): 581 doi: 10.1097/MPA.0b013e3181c314cd
|
16 |
Atsushi Masamune, Shin Hamada, Kazuhiro Kikuta, Tetsuya Takikawa, Shin Miura, Eriko Nakano, Tooru Shimosegawa. The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice. Scandinavian Journal of Gastroenterology 2013; 48(5): 602 doi: 10.3109/00365521.2013.777776
|
17 |
Andrew Cannon, Christopher Michael Thompson, Rakesh Bhatia, Katharine Anne Armstrong, Joyce Christopher Solheim, Sushil Kumar, Surinder Kumar Batra. Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma. Journal of Gastroenterology 2021; 56(8): 689 doi: 10.1007/s00535-021-01800-4
|
18 |
Ruixia Liu, Haiyu Qi, Jing Wang, Yan Wang, Lijian Cui, Yan Wen, Chenghong Yin. Ulinastatin activates the renin–angiotensin system to ameliorate the pathophysiology of severe acute pancreatitis. Journal of Gastroenterology and Hepatology 2014; 29(6): 1328 doi: 10.1111/jgh.12584
|
19 |
Marcelo Cerullo, Faiz Gani, Sophia Y. Chen, Joseph K. Canner, Timothy M. Pawlik. Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer. World Journal of Surgery 2017; 41(9): 2361 doi: 10.1007/s00268-017-4021-8
|
20 |
Micheline M. de Resende, Andrew S. Greene. Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation. American Journal of Physiology-Heart and Circulatory Physiology 2008; 294(6): H2814 doi: 10.1152/ajpheart.00095.2008
|
21 |
Xiping Zhang, Li Chen, Luping Luo, Hua Tian, Guanghua Feng, Yang Cai, Rujun Xu, Keyi Wang, Zhiwei Wang. Study of the Protective Effects of Dexamethasone on Ileum Mucosa Injury in Rats With Severe Acute Pancreatitis. Pancreas 2008; 37(3): e74 doi: 10.1097/MPA.0b013e3181800d11
|
22 |
Jeroni Luna, Maria Carme Masamunt, Ian Craig Lawrance, Miquel Sans. Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011; 300(5): G703 doi: 10.1152/ajpgi.00504.2010
|
23 |
Min Ae Cho, Soo Young Jeong, Insuk Sohn, Myeong-Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Chel Hun Choi. Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients. Cancer Research and Treatment 2020; 52(2): 645 doi: 10.4143/crt.2019.509
|